Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Scott A. Armstrong, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Scott Armstrong and Florian Perner.
Connection Strength

2.491
  1. Targeting Chromatin Complexes in Myeloid Malignancies and Beyond: From Basic Mechanisms to Clinical Innovation. Cells. 2020 12 21; 9(12).
    View in: PubMed
    Score: 0.885
  2. IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia. Nat Cancer. 2022 05; 3(5):595-613.
    View in: PubMed
    Score: 0.243
  3. MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape. Mol Cell. 2022 03 17; 82(6):1140-1155.e11.
    View in: PubMed
    Score: 0.240
  4. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. Blood. 2022 02 10; 139(6):894-906.
    View in: PubMed
    Score: 0.239
  5. YBX1 mediates translation of oncogenic transcripts to control cell competition in AML. Leukemia. 2022 02; 36(2):426-437.
    View in: PubMed
    Score: 0.232
  6. Histone PTM Crosstalk Stimulates Dot1 Methyltransferase Activity. Trends Biochem Sci. 2021 07; 46(7):522-524.
    View in: PubMed
    Score: 0.226
  7. Novel inhibitors of the histone methyltransferase DOT1L show potent antileukemic activity in patient-derived xenografts. Blood. 2020 10 22; 136(17):1983-1988.
    View in: PubMed
    Score: 0.219
  8. A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia. Cancer Cell. 2019 12 09; 36(6):660-673.e11.
    View in: PubMed
    Score: 0.206
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.